|
Persistent HPV in Women at Risk for Cervix Cancer
|
5U01CA078527-12
|
$590,661
|
$295,331
|
BURK, ROBERT
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
$314,179
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Pro & Anti-Inflammatory Cytokines in Colorectal Cancer
|
5R01CA122654-02
|
$625,384
|
$469,038
|
HO, GLORIA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
HPV & cervix neoplasia in a large, long-term HIV+ cohort
|
5R01CA085178-10
|
$692,565
|
$692,565
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.
|
5U01CA098710-06
|
$550,218
|
$550,218
|
THUN, MICHAEL
|
AMERICAN CANCER SOCIETY, INC.
|
|
The Epidemiologic Effects of HAART on HIV-related Anal Cancer and Anal Dysplasia
|
5K23CA124318-04
|
$137,700
|
$137,700
|
Chiao, Elizabeth
|
BAYLOR COLLEGE OF MEDICINE
|
|
Nonhomologous end-joinging polymorphisms and HPV integration in cervical dysplasi
|
1R03CA143965-01
|
$76,750
|
$76,750
|
Scheurer, Michael
|
BAYLOR COLLEGE OF MEDICINE
|
|
Infection and Inflammation in Adult Gliomas
|
5K07CA131505-02
|
$135,445
|
$135,445
|
Scheurer, Michael
|
BAYLOR COLLEGE OF MEDICINE
|
|
Familial and Early Onset Colorectal Cancer
|
2R01CA072851-14
|
$342,796
|
$171,398
|
BOLAND, CLEMENT
|
BAYLOR RESEARCH INSTITUTE
|
|
Topic 234 - Automated Patterns Recognition in Satellite Imagery
|
N44CO900024-000
|
$750,000
|
$375,000
|
Goovaerts, Pierre
|
BIO-ANALYTICS INC:1132567
|
|
Modification of tamoxifen effectiveness by gene polymorphisms and other drugs
|
5R01CA118708-04
|
$234,985
|
$234,985
|
LASH, TIMOTHY
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Energy Balance, IGF Dysregulation and Multiple Myeloma
|
5K07CA115687-04
|
$140,130
|
$140,130
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Meningioma: Risk Factors and Quality of Life
|
5R01CA109461-04
|
$229,698
|
$114,849
|
BLACK, PETER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Partners Southwestern Clinical Epidemiology/Validation
|
5U01CA086381-10
|
$917,404
|
$917,404
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Oxidative Stree, Antioxidants and Risk of Breast Cancer: A Prospective Analysis
|
1R01CA131218-01A2
|
$578,243
|
$578,243
|
Eliassen, A. Heather
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Prospective Study of DNA Repair Gene Variants in Breast Cancer
|
5R01CA118447-03
|
$329,823
|
$329,823
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma
|
5R01CA122838-02
|
$360,731
|
$360,731
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Prospective study of telomere length and melanoma risk
|
5R03CA133914-02
|
$87,608
|
$87,608
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biochemical Markers in the Nurses? Health Study Cohort
|
2U01CA049449-20A1
|
$1,118,195
|
$894,556
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-10
|
$4,850,916
|
$4,850,916
|
Hankinson, Susan
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Breast Cancer
|
5R01CA065725-13
|
$408,636
|
$408,636
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3
|
5U01CA098233-07
|
$1,403,224
|
$701,612
|
HUNTER, David
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
5P50CA093683-07
|
$2,300,000
|
$460,000
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Sex steroid hormones, gene variants, and colorectal cancer
|
5R01CA126846-02
|
$516,142
|
$516,142
|
Lin, Jennifer
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Imprinted genes as risk and early detection markers for breast cancer
|
1R03CA143967-01
|
$88,917
|
$88,917
|
MICHELS, KARIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in MicroRNA-Related Genes and Skin Cancer Risk
|
1R03CA139496-01
|
$88,500
|
$88,500
|
Nan, Hongmei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Testing and Cancer Screening in Hereditary Cancer Syndromes
|
5K07CA120448-03
|
$141,548
|
$49,542
|
STOFFEL, ELENA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Whole Genome Association Study of Mammographic Density
|
1R01CA131332-01A2
|
$459,193
|
$459,193
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Benign Breast Disease and Risk of Breast Cancer
|
5R01CA046475-18
|
$340,162
|
$340,162
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Predictors of Mammographic Density
|
5R01CA124865-02
|
$326,813
|
$163,407
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cysteine, Related Gene Variants and Breast Cancer Risk
|
5R01CA124857-03
|
$325,266
|
$162,633
|
Willett, Walter
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Estrogen and Progesterone-related Gene Variants and Colorectal Cancer Risk
|
5R01CA123089-04
|
$339,313
|
$254,485
|
ZHANG, SHUMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Boston Collaborative Oral Cancer Study
|
5R01CA078609-10
|
$393,709
|
$393,709
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
The Molecular Epidemiology of Bladder Cancer
|
5R01CA121147-04
|
$398,652
|
$398,652
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
The Epidemiology of Molecular Alterations in Mesothelioma
|
5R01CA126939-02
|
$494,897
|
$247,449
|
Kelsey, Karl
|
BROWN UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA030199-28S1
|
$118,420
|
$3,553
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA030199-28S2
|
$3,387,817
|
$101,635
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Mitochondrial DNA Mutations in Pancreatic Cancer
|
1R21CA133080-01A1
|
$248,462
|
$248,462
|
Tranah, Gregory
|
CALIFORNIA PACIFIC MED CTR RES INSTITUTE
|
|
Ontario Familial Breast Cancer Registry
|
5U01CA069467-15
|
$720,409
|
$720,409
|
ANDRULIS, IRENE
|
CANCER CARE ONTARIO
|
|
The Colon Cancer Family Registry: Ontario
|
3U24CA074783-10S1
|
$38,440
|
$38,440
|
GALLINGER, STEVEN
|
CANCER CARE ONTARIO
|
|
The Colon Cancer Family Registry: Ontario
|
5U24CA074783-11
|
$1,106,753
|
$1,106,753
|
GALLINGER, STEVEN
|
CANCER CARE ONTARIO
|
|
Training in Computational Genomic Epidemiology of Cancer
|
5R25CA094186-08
|
$515,312
|
$257,656
|
Elston, Robert
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
$2,808
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
$3,996
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
$194,618
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Obesity-Related Insulin Resistance Signaling Pathway Factors and Colon Cancer
|
1R01CA136726-01A1
|
$544,049
|
$544,049
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Pathway Modeling of Complex Toxin Response and Energy Balance Systems in Cancer
|
5K07CA129162-02
|
$126,065
|
$126,065
|
Nock, Nora
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Genetic variants in the PI3K pathway in mammographic density and breast cancer
|
1K07CA136758-01A1
|
$122,432
|
$122,432
|
THOMPSON, CHERYL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-05
|
$256,197
|
$256,197
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-18
|
$266,860
|
$266,860
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
Total relevant funding to Biochemical Epidemiology for this search: $238,806,490
|